Streetbeat News

Regulatory

PLL

Piedmont Lithium's stock price increased following the announcement that the company has received mining permit approval for its Carolina Lithium project, allowing for construction, operation, and reclamation.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:44 am

SNGX

Soligenix shares surged following the FDA's grant of orphan drug designation to MarVax's active ingredient for MARV infection prevention and post-exposure prophylaxis. This designation could potentially accelerate MarVax's development and approval process, highlighting Soligenix's commitment to addressing rare diseases.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:37 am

IVVD

Invivyd has been granted Healthcare Common Procedure Coding System (HCPCS) reimbursement codes by the U.S. Centers for Medicare & Medicaid Services for its product Pemgarda. This development is crucial for Invivyd as it ensures that Pemgarda will be covered by Medicare and potentially other insurance providers, facilitating access for patients and potentially boosting the product's sales.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:34 am

SNGX

The FDA has awarded Soligenix Orphan Drug Designation for the active ingredient in MarVaxor, aimed at the prevention and post-exposure prophylaxis of Marburg virus infection. This designation can provide benefits such as market exclusivity upon approval, assistance in the drug development process, and tax credits.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:31 am

NMRA

Neumora Therapeutics' stock is trading lower following the FDA's decision to place a clinical hold on its Phase 1 NMRA-266 study.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:24 am

TFFP

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) announced additional positive data from the Phase 2 study of Tacrolimus Inhalation Powder (TFF TAC) for preventing organ rejection in lung transplant recipients. The data was presented at the ISHLT 44th Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:11 am

INMD

InMode Ltd. (NASDAQ:INMD) is defending its U.S. Patent No. 8,961,511 on feminine rejuvenation technology against a review request by BTL Industries to the USPTO. This follows InMode's lawsuit against BTL for allegedly infringing this patent with their UltraFemme 360 and EmFemme 360 products. The legal battle is ongoing in the United States District Court for the Central District of California.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:08 am

PLTR

Palantir Technologies Inc. (PLTR) is part of the Colorado-Wyoming Regional Innovation Engine team that won the US National Science Foundation's first Regional Innovation Engines program grant. This award places the team, led by Innosphere Ventures, as a leader in the US environmental and climate technology sector.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:01 am

PLL

Piedmont Lithium (NASDAQ:PLL) has received approval from the North Carolina Department of Environmental Quality for a mining permit for the Carolina Lithium project in Gaston County, North Carolina. This permit allows for the construction, operation, and reclamation of the lithium project, which is crucial for the U.S. electric vehicle supply chain.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 10:56 am

EWY

SPY

SSNLF

The U.S. government is set to provide $6.4 billion in grants to Samsung Electronics as part of the Chips Act, aimed at bolstering semiconductor production.

Portfolio Pulse from Charles Gross

April 15, 2024 | 9:23 am